Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
58.68 (1y: +21%)
Market Cap 10.81 B P/E(ttm) 14.90
Enterprise Value 10.95 B P/B 3.00
SNN- NYSE (USA)
Smith & Nephew PLC
  • Currently 2.5/5
Business Predictability Rank: 2.5-Star (On Watch)
Back Testing Results:
Average gain of all 2.5-Star stocks: 7.3% per year.
% of Stocks that are in still loss if held for 10yrs: 18%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$58.68
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry		 vs
history
Cash to Debt 0.38
SNN's Cash to Debt is ranked lower than
51% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. SNN: 0.38 )
SNN' s 10-Year Cash to Debt Range
Min: 0.07   Max: 2.58
Current: 0.38
0.07
2.58
Equity to Asset 0.688
SNN's Equity to Asset is ranked higher than
71% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. SNN: 0.688 )
SNN' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.69
Current: 0.69
0.34
0.69
Interest Coverage 846
SNN's Interest Coverage is ranked higher than
78% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 9.60 vs. SNN: 846 )
SNN' s 10-Year Interest Coverage Range
Min: 9   Max: No Debt
Current: 846
F-Score: 5
Z-Score: 6.92
M-Score: -2.48
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry		 vs
history
Operating margin (%) 20.40
SNN's Operating margin (%) is ranked higher than
91% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. SNN: 20.40 )
SNN' s 10-Year Operating margin (%) Range
Min: 13.6   Max: 23.2
Current: 20.4
13.6
23.2
Net-margin (%) 17.6
SNN's Net-margin (%) is ranked higher than
92% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 2.50 vs. SNN: 17.6 )
SNN' s 10-Year Net-margin (%) Range
Min: 9.4   Max: 26.8
Current: 17.6
9.4
26.8
ROE (%) 18.8
SNN's ROE (%) is ranked higher than
95% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. SNN: 18.8 )
SNN' s 10-Year ROE (%) Range
Min: 17.2   Max: 62.3
Current: 18.8
17.2
62.3
ROA (%) 12.9
SNN's ROA (%) is ranked higher than
94% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SNN: 12.9 )
SNN' s 10-Year ROA (%) Range
Min: 7.1   Max: 23.1
Current: 12.9
7.1
23.1
ROC (Joel Greenblatt) (%) 43.80
SNN's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 9.60 vs. SNN: 43.80 )
SNN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 28.8   Max: 47.1
Current: 43.8
28.8
47.1
Revenue Growth (%) 1.9
SNN's Revenue Growth (%) is ranked higher than
76% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 1.9 )
SNN' s 10-Year Revenue Growth (%) Range
Min: -3.7   Max: 33.1
Current: 1.9
-3.7
33.1
EBITDA Growth (%) 2.6
SNN's EBITDA Growth (%) is ranked higher than
85% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 2.6 )
SNN' s 10-Year EBITDA Growth (%) Range
Min: -1.8   Max: 37.2
Current: 2.6
-1.8
37.2
EPS Growth (%) 11
SNN's EPS Growth (%) is ranked higher than
92% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 11 )
SNN' s 10-Year EPS Growth (%) Range
Min: -9.3   Max: 29.2
Current: 11
-9.3
29.2
ยป SNN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

SNN Guru Trades in Q2 2012

David Dreman 75,878 sh (+10.41%)
Pioneer Investments 126,204 sh (+2.58%)
John Hussman 12,500 sh (unchged)
Ken Fisher 1,486,280 sh (-28.11%)
Jim Simons 107,200 sh (-29.24%)
» More
Q3 2012

SNN Guru Trades in Q3 2012

David Dreman 81,193 sh (+7%)
John Hussman 12,500 sh (unchged)
Pioneer Investments 89,533 sh (-29.06%)
Ken Fisher 1,028,693 sh (-30.79%)
Jim Simons 43,100 sh (-59.79%)
» More
Q4 2012

SNN Guru Trades in Q4 2012

John Hussman 19,500 sh (+56%)
David Dreman 86,105 sh (+6.05%)
Pioneer Investments 88,819 sh (-0.8%)
Ken Fisher 1,013,424 sh (-1.48%)
Jim Simons 18,000 sh (-58.24%)
» More
Q1 2013

SNN Guru Trades in Q1 2013

Jim Simons 72,800 sh (+304.44%)
Ken Fisher 1,042,437 sh (+2.86%)
David Dreman 88,549 sh (+2.84%)
Pioneer Investments 89,405 sh (+0.66%)
John Hussman 19,500 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Hussman 2012-12-31 Add 56%0.01%$51.03 - $55.66 $ 58.6810%19500
David Dreman 2011-06-30 Add 43.79%0.02%$51.11 - $58.18 $ 58.687%60856
John Hussman 2011-06-30 Add 83.33%$51.11 - $58.18 $ 58.687%11000
David Dreman 2011-03-31 Add 34.27%0.01%$50.83 - $60.19 $ 58.684%42323
John Hussman 2010-12-31 Add 50%$43.09 - $52.52 $ 58.6824%6000
David Dreman 2010-09-30 Add 22.34%0.01%$41.29 - $47.45 $ 58.6833%28478
John Hussman 2010-09-30 Add 60%$41.29 - $47.45 $ 58.6833%4000
David Dreman 2010-06-30 New Buy0.03%$43.26 - $53.94 $ 58.6820%23278
John Hussman 2010-06-30 New Buy$43.26 - $53.94 $ 58.6820%2500
Premium More recent guru trades are included for Premium Members only!!
ยป Financial Charts

Peter Lynch Chart

Ratios

vs
industry		 vs
history
P/E(ttm) 14.90
SNN's P/E(ttm) is ranked higher than
83% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 22.90 vs. SNN: 14.90 )
SNN' s 10-Year P/E(ttm) Range
Min: 4.93   Max: 63.82
Current: 14.9
4.93
63.82
P/B 3.00
SNN's P/B is ranked higher than
53% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. SNN: 3.00 )
SNN' s 10-Year P/B Range
Min: 2.33   Max: 70.75
Current: 3
2.33
70.75
P/S 2.57
SNN's P/S is ranked higher than
57% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. SNN: 2.57 )
SNN' s 10-Year P/S Range
Min: 1.52   Max: 5.66
Current: 2.57
1.52
5.66
PFCF 15.70
SNN's PFCF is ranked higher than
76% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 21.03 vs. SNN: 15.70 )
SNN' s 10-Year PFCF Range
Min: 12.87   Max: 212
Current: 15.7
12.87
212
EV-to-EBIT 13.3
SNN's EV-to-EBIT is ranked higher than
80% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 18.50 vs. SNN: 13.3 )
SNN' s 10-Year EV-to-EBIT Range
Min: 8.6   Max: 678.6
Current: 13.3
8.6
678.6
PEG 2.5
SNN's PEG is ranked higher than
63% of the 84 Companies
in the Global Medical Devices industry.

( Industry Median: 2.22 vs. SNN: 2.5 )
SNN' s 10-Year PEG Range
Min: 0.31   Max: 2.5
Current: 2.5
0.31
2.5
Shiller P/E 19.1
SNN's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Devices industry.

( Industry Median: vs. SNN: 19.1 )
SNN' s 10-Year Shiller P/E Range
Min: 15.54   Max: 279
Current: 19.1
15.54
279

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 2.19
SNN's Dividend Yield is ranked higher than
92% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 2.19 )
SNN' s 10-Year Dividend Yield Range
Min: 0.65   Max: 17.37
Current: 2.19
0.65
17.37
Dividend Payout 0.2574
SNN's Dividend Payout is ranked higher than
55% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 0.30 vs. SNN: 0.2574 )
SNN' s 10-Year Dividend Payout Range
Min: 0.21   Max: 7.15
Current: 0.26
0.21
7.15
Dividend growth (3y) 11
SNN's Dividend growth (3y) is ranked higher than
98% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 11 )
SNN' s 10-Year Dividend growth (3y) Range
Min: -41.9   Max: 11
Current: 11
-41.9
11
Yield on cost (5-Year) 4.42
SNN's Yield on cost (5-Year) is ranked higher than
97% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 4.42 )
SNN' s 10-Year Yield on cost (5-Year) Range
Min: 1.31   Max: 34.94
Current: 4.42
1.31
34.94
Share Buyback Rate -0.4
SNN's Share Buyback Rate is ranked higher than
56% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: -0.4 )
SNN' s 10-Year Share Buyback Rate Range
Min: 18.2   Max: -3.6
Current: -0.4

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 9.1
SNN's Price/Net Current Asset Value is ranked higher than
73% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 14.30 vs. SNN: 9.1 )
SNN' s 10-Year Price/Net Current Asset Value Range
Min: 5.5   Max: 25.9
Current: 9.1
5.5
25.9
Price/Tangible Book 6.9
SNN's Price/Tangible Book is ranked lower than
56% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. SNN: 6.9 )
SNN' s 10-Year Price/Tangible Book Range
Min: 5.3   Max: 54.4
Current: 6.9
5.3
54.4
Price/DCF (Projected) 1.3
SNN's Price/DCF (Projected) is ranked higher than
73% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. SNN: 1.3 )
SNN' s 10-Year Price/DCF (Projected) Range
Min: 1.2   Max: 13.1
Current: 1.3
1.2
13.1
Price/Median PS Value 0.9
SNN's Price/Median PS Value is ranked higher than
73% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. SNN: 0.9 )
SNN' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 1.9
Current: 0.9
0.5
1.9
Price/Peter Lynch Fair Value 1.9
SNN's Price/Peter Lynch Fair Value is ranked higher than
75% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. SNN: 1.9 )
SNN' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.7   Max: 1.6
Current: 1.9
0.7
1.6
Price/Graham Number 2
SNN's Price/Graham Number is ranked higher than
62% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SNN: 2 )
SNN' s 10-Year Price/Graham Number Range
Min: 1.5   Max: 10.4
Current: 2
1.5
10.4
Earnings Yield (Greenblatt) 7.50
SNN's Earnings Yield (Greenblatt) is ranked higher than
87% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. SNN: 7.50 )
SNN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 11.6
Current: 7.5
0.1
11.6
Forward Rate of Return (Yacktman) 11.34
SNN's Forward Rate of Return (Yacktman) is ranked higher than
94% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SNN: 11.34 )
SNN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 11.9   Max: 62.7
Current: 11.34
11.9
62.7

Business Description

Smith & Nephew PLC, together with its subsidiaries, is engaged in developing, manufacturing, marketing and selling medical devices in the sectors of Orthopaedics, Endoscopy and Advanced Wound Management. Its three operating segments are Orthopaedics, Endoscopy and Advanced Wound Management. Orthopaedic comprises reconstruction, trauma and clinical therapies products. Orthopaedic reconstruction implants include hip, knee and shoulder joints as well as ancillary products such as bone cement. Orthopaedic trauma fixation products consist of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilisation of severe fractures and deformity correction procedures. Endoscopy business develops and commercialises endoscopic (minimally invasive surgery) techniques, educational programmes and value-added services for surgeons to treat and repair soft tissue and articulating joints. The business focuses on the arthroscopy sector of the endoscopy market. Advanced Wound Management business offers a range of products from initial wound bed preparation through to full wound closure. These products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers. There are also products for the treatment of wounds such as burns and invasive surgery that impact the wider population. The group operates in the Europe, United States, Africa, Asia, Australasia and other America.
Company Website
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
Traded in other countries:SN..UK, NPW1.Germany
ยป More Articles for NYSE:SNN

Headlines

Articles On GuruFocus.com
Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
The Best Dividends on April 18, 2012 Apr 18 2012 
5 Healthcare Stocks to Consider Today Mar 21 2012 
medical Feb 29 2012 
Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 
comment on SNN Nov 08 2011 
predictable hussma Nov 08 2011 
predictable hussman Nov 01 2011 
medicina Oct 27 2011 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK